[Polyvalent intravenous immunoglobulins in systemic lupus].

Rev Med Interne

Service de médecine interne, Hôpital de la Pitié-Salpêtrière, Paris, France.

Published: October 1999

Purpose: To evaluate intravenous immunoglobulins (IVIG) treatment, which is immunomodulatory but not immunosuppressive, in SLE.

Main Issues: IVIG indications in SLE could be categorized as already validated as for chronic polyradiculoneuropathy or thrombocytopenia; failure of classical treatment in threatening active disease; undetermined manifestation as reactive hemophagocytic syndrome which could be both disease-specific or iatrogenic, infection-related. To date, no published study has firmly established the efficacy of IVIG in SLE.

Conclusion: IVIG therapy in SLE should be evaluated in prospective trials.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0248-8663(00)88671-3DOI Listing

Publication Analysis

Top Keywords

intravenous immunoglobulins
8
[polyvalent intravenous
4
immunoglobulins systemic
4
systemic lupus]
4
lupus] purpose
4
purpose evaluate
4
evaluate intravenous
4
ivig
4
immunoglobulins ivig
4
ivig treatment
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!